Terry-Ann Burrell - Jun 28, 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
CFO
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Jun 28, 2021
Transactions value $
-$4,230,416
Form type
4
Date filed
6/30/2021, 06:00 PM
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $616K +45K +181.39% $13.68 69.8K Jun 28, 2021 Direct F1
transaction BEAM Common Stock Sale -$114K -1.1K -1.58% $103.86 68.7K Jun 28, 2021 Direct F2, F3
transaction BEAM Common Stock Sale -$197K -1.88K -2.74% $104.63 66.8K Jun 28, 2021 Direct F2, F4
transaction BEAM Common Stock Sale -$550K -5.22K -7.81% $105.34 61.6K Jun 28, 2021 Direct F2, F5
transaction BEAM Common Stock Sale -$945K -8.91K -14.46% $106.13 52.7K Jun 28, 2021 Direct F2, F6
transaction BEAM Common Stock Sale -$353K -3.29K -6.24% $107.20 49.4K Jun 28, 2021 Direct F2, F7
transaction BEAM Common Stock Sale -$521K -4.8K -9.72% $108.45 44.6K Jun 28, 2021 Direct F2, F8
transaction BEAM Common Stock Sale -$2.17M -19.8K -44.39% $109.41 24.8K Jun 28, 2021 Direct F2, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -45K -12.57% $0.00 313K Jun 28, 2021 Common Stock 45K $13.68 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.74 to $103.97, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.58 to $104.96, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.95, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.89, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.90, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.98, inclusive.
F10 The option vests as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested.